Skip to main content
Erschienen in: Surgical Endoscopy 9/2017

15.12.2016

Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study

verfasst von: Chang-Ming Huang, Chen-Bin Lv, Jian-Xian Lin, Qi-Yue Chen, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Long-Long Cao, Mi Lin, Ru-Hong Tu

Erschienen in: Surgical Endoscopy | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Few studies have evaluated the outcomes of laparoscopic-assisted total gastrectomy (LATG) for Siewert type II and III adenocarcinoma of the esophagogastric junction (AEG). Thus, aim of this study was to investigate the surgical outcomes of LATG for Siewert type II and III AEG.

Methods

Clinical data for 700 Siewert type II and III AEG patients were analyzed retrospectively. The short- and long-term outcomes were compared between the matched groups using a propensity score matching method.

Results

Before matching, the comorbidities, Siewert classifications and tumor invasion depths significantly differed between the LATG and open total gastrectomy (OTG) groups. After matching, the clinicopathologic characteristics were well balanced between the two groups. In addition, after matching, decreases in the operative time, amount of blood loss, time to resumption of a semifluid diet, and length of hospital stay and an increased number of lymph nodes (LNs) retrieved were observed in the LATG group compared with the OTG group. Further, a significantly higher 3-year overall survival rate (81.3 vs 66.4%; P = 0.011) and disease-free survival rate (77.5 vs 63.8%; P = 0.040) were observed for the Siewert type II AEG patients in the LATG group compared with those in the OTG group; however, the survival rates were similar for the Siewert type III AEG patients in the two groups (P = 0.853 and P = 0.844, respectively).

Conclusions

LATG is associated with better short-term outcomes for Siewert type II and III AEG. In addition, it may result in an increased number of retrieved LNs and better long-term survival for Siewert type II AEG patients in particular.
Literatur
1.
Zurück zum Zitat Vial M, Grande L, Pera M (2010) Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res 182:1–17PubMed Vial M, Grande L, Pera M (2010) Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res 182:1–17PubMed
2.
Zurück zum Zitat Buas MF, Vaughan TL (2013) Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 23:3–9CrossRefPubMedPubMedCentral Buas MF, Vaughan TL (2013) Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 23:3–9CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRefPubMed Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457–1459CrossRefPubMed
4.
Zurück zum Zitat Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, Hsu WH, Li AF, Lui WY (2009) Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol 16:3237–3244CrossRefPubMed Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, Hsu WH, Li AF, Lui WY (2009) Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol 16:3237–3244CrossRefPubMed
5.
Zurück zum Zitat Bai JG, Lv Y, Dang CX (2006) Adenocarcinoma of the esophagogastric junction in China according to Siewert’s classification. Jpn J Clin Oncol 36:364–367CrossRefPubMed Bai JG, Lv Y, Dang CX (2006) Adenocarcinoma of the esophagogastric junction in China according to Siewert’s classification. Jpn J Clin Oncol 36:364–367CrossRefPubMed
6.
Zurück zum Zitat Hasegawa S, Yoshikawa T (2010) Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer 13:63–73CrossRefPubMed Hasegawa S, Yoshikawa T (2010) Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer 13:63–73CrossRefPubMed
7.
Zurück zum Zitat Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T (2012) Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol 19:677–683CrossRefPubMed Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T (2012) Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol 19:677–683CrossRefPubMed
8.
Zurück zum Zitat Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4:146–148PubMed Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4:146–148PubMed
9.
Zurück zum Zitat Kitano S, Shiraishi N, Fujii K, Yasuda K, Inomata M, Adachi Y (2002) A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery 131:S306–S311CrossRefPubMed Kitano S, Shiraishi N, Fujii K, Yasuda K, Inomata M, Adachi Y (2002) A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery 131:S306–S311CrossRefPubMed
10.
Zurück zum Zitat Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ, Bae JM (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248:721–727CrossRefPubMed Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ, Bae JM (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248:721–727CrossRefPubMed
11.
Zurück zum Zitat Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY (2010) Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report–a phase III multicenter, prospective, randomized trial (KLASS trial). Ann Surg 251:417–420CrossRefPubMed Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY (2010) Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report–a phase III multicenter, prospective, randomized trial (KLASS trial). Ann Surg 251:417–420CrossRefPubMed
12.
Zurück zum Zitat Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C (2005) Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 241:232–237CrossRefPubMedPubMedCentral Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C (2005) Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 241:232–237CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Wada N, Kurokawa Y, Takiguchi S, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Mori M, Doki Y (2014) Feasibility of laparoscopy-assisted total gastrectomy in patients with clinical stage I gastric cancer. Gastric Cancer 17:137–140CrossRefPubMed Wada N, Kurokawa Y, Takiguchi S, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Mori M, Doki Y (2014) Feasibility of laparoscopy-assisted total gastrectomy in patients with clinical stage I gastric cancer. Gastric Cancer 17:137–140CrossRefPubMed
14.
Zurück zum Zitat Lee MS, Lee JH, Park do J, Lee HJ, Kim HH, Yang HK (2013) Comparison of short- and long-term outcomes of laparoscopic-assisted total gastrectomy and open total gastrectomy in gastric cancer patients. Surg Endosc 27:2598–2605CrossRefPubMed Lee MS, Lee JH, Park do J, Lee HJ, Kim HH, Yang HK (2013) Comparison of short- and long-term outcomes of laparoscopic-assisted total gastrectomy and open total gastrectomy in gastric cancer patients. Surg Endosc 27:2598–2605CrossRefPubMed
15.
Zurück zum Zitat Lee SR, Kim HO, Son BH, Shin JH, Yoo CH (2014) Laparoscopic-assisted total gastrectomy versus open total gastrectomy for upper and middle gastric cancer in short-term and long-term outcomes. Surg Laparosc Endosc Percutan Tech 24:277–282CrossRefPubMed Lee SR, Kim HO, Son BH, Shin JH, Yoo CH (2014) Laparoscopic-assisted total gastrectomy versus open total gastrectomy for upper and middle gastric cancer in short-term and long-term outcomes. Surg Laparosc Endosc Percutan Tech 24:277–282CrossRefPubMed
16.
Zurück zum Zitat Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246:1–8CrossRefPubMedPubMedCentral Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246:1–8CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474CrossRefPubMed Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474CrossRefPubMed
18.
Zurück zum Zitat Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (version 3). Gastric Cancer 14:113–123CrossRef Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (version 3). Gastric Cancer 14:113–123CrossRef
19.
Zurück zum Zitat Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Yang XT (2015) Laparoscopic suprapancreatic lymph node dissection for advanced gastric cancer using a left-sided approach. Ann Surg Oncol 22:2351CrossRefPubMed Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Yang XT (2015) Laparoscopic suprapancreatic lymph node dissection for advanced gastric cancer using a left-sided approach. Ann Surg Oncol 22:2351CrossRefPubMed
20.
Zurück zum Zitat Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW (2014) Huang’s three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer. Chin J Cancer Res 26:208–210PubMedPubMedCentral Huang CM, Chen QY, Lin JX, Zheng CH, Li P, Xie JW (2014) Huang’s three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer. Chin J Cancer Res 26:208–210PubMedPubMedCentral
21.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Hong L, Han Y, Jin Y, Zhang H, Zhao Q (2013) The short-term outcome in esophagogastric junctional adenocarcinoma patients receiving total gastrectomy: laparoscopic versus open gastrectomy–a retrospective cohort study. Int J Surg 11:957–961CrossRefPubMed Hong L, Han Y, Jin Y, Zhang H, Zhao Q (2013) The short-term outcome in esophagogastric junctional adenocarcinoma patients receiving total gastrectomy: laparoscopic versus open gastrectomy–a retrospective cohort study. Int J Surg 11:957–961CrossRefPubMed
23.
Zurück zum Zitat Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ, Whang EE (2004) Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 199:880–886CrossRefPubMed Ito H, Clancy TE, Osteen RT, Swanson RS, Bueno R, Sugarbaker DJ, Ashley SW, Zinner MJ, Whang EE (2004) Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 199:880–886CrossRefPubMed
24.
Zurück zum Zitat Rudiger Siewert J, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232:353–361CrossRefPubMedPubMedCentral Rudiger Siewert J, Feith M, Werner M, Stein HJ (2000) Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 232:353–361CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Parry K, Haverkamp L, Bruijnen RC, Siersema PD, Ruurda JP, van Hillegersberg R (2015) Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol 22:597–603CrossRefPubMed Parry K, Haverkamp L, Bruijnen RC, Siersema PD, Ruurda JP, van Hillegersberg R (2015) Surgical treatment of adenocarcinomas of the gastro-esophageal junction. Ann Surg Oncol 22:597–603CrossRefPubMed
26.
Zurück zum Zitat Siewert JR, Feith M (2007) Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer. J Am Coll Surg 205:S49–S53CrossRefPubMed Siewert JR, Feith M (2007) Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer. J Am Coll Surg 205:S49–S53CrossRefPubMed
27.
Zurück zum Zitat Polkowski WP, van Lanschot JJ (2014) Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 101:735CrossRefPubMed Polkowski WP, van Lanschot JJ (2014) Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 101:735CrossRefPubMed
28.
Zurück zum Zitat Haverkamp L, Ruurda JP, van Leeuwen MS, Siersema PD, van Hillegersberg R (2014) Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction. Surg Oncol 23:222–228CrossRefPubMed Haverkamp L, Ruurda JP, van Leeuwen MS, Siersema PD, van Hillegersberg R (2014) Systematic review of the surgical strategies of adenocarcinomas of the gastroesophageal junction. Surg Oncol 23:222–228CrossRefPubMed
29.
Zurück zum Zitat Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, Nashimoto A, Hiratsuka M (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7:644–651CrossRefPubMed Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, Nashimoto A, Hiratsuka M (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7:644–651CrossRefPubMed
30.
Zurück zum Zitat Kurokawa Y, Sasako M, Sano T, Yoshikawa T, Iwasaki Y, Nashimoto A, Ito S, Kurita A, Mizusawa J, Nakamura K (2015) Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg 102:341–348CrossRefPubMedPubMedCentral Kurokawa Y, Sasako M, Sano T, Yoshikawa T, Iwasaki Y, Nashimoto A, Ito S, Kurita A, Mizusawa J, Nakamura K (2015) Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg 102:341–348CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R (2013) Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc 27:1509–1520CrossRefPubMed Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R (2013) Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc 27:1509–1520CrossRefPubMed
32.
Zurück zum Zitat Nakata K, Nagai E, Ohuchida K, Shimizu S, Tanaka M (2015) Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes. Surg Endosc 29:1817–1822CrossRefPubMed Nakata K, Nagai E, Ohuchida K, Shimizu S, Tanaka M (2015) Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes. Surg Endosc 29:1817–1822CrossRefPubMed
33.
Zurück zum Zitat Jeong O, Jung MR, Kim GY, Kim HS, Ryu SY, Park YK (2013) Comparison of short-term surgical outcomes between laparoscopic and open total gastrectomy for gastric carcinoma: case-control study using propensity score matching method. J Am Coll Surg 216:184–191CrossRefPubMed Jeong O, Jung MR, Kim GY, Kim HS, Ryu SY, Park YK (2013) Comparison of short-term surgical outcomes between laparoscopic and open total gastrectomy for gastric carcinoma: case-control study using propensity score matching method. J Am Coll Surg 216:184–191CrossRefPubMed
34.
Zurück zum Zitat Palanivelu C, Prakash A, Parthasarathi R, Senthilkumar R, Senthilnathan PR, Rajapandian S (2007) Laparoscopic esophagogastrectomy without thoracic or cervical access for adenocarcinoma of the gastroesophageal junction: an Indian experience from a tertiary center. Surg Endosc 21:16–20CrossRefPubMed Palanivelu C, Prakash A, Parthasarathi R, Senthilkumar R, Senthilnathan PR, Rajapandian S (2007) Laparoscopic esophagogastrectomy without thoracic or cervical access for adenocarcinoma of the gastroesophageal junction: an Indian experience from a tertiary center. Surg Endosc 21:16–20CrossRefPubMed
35.
Zurück zum Zitat Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M, Okazumi S, Katoh R, Kinoshita T (2012) Laparoscopic transhiatal resection for Siewert type II adenocarcinoma of the esophagogastric junction: operative technique and initial results. Surg Laparosc Endosc Percutan Tech 22:e199–e203CrossRefPubMed Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M, Okazumi S, Katoh R, Kinoshita T (2012) Laparoscopic transhiatal resection for Siewert type II adenocarcinoma of the esophagogastric junction: operative technique and initial results. Surg Laparosc Endosc Percutan Tech 22:e199–e203CrossRefPubMed
36.
Zurück zum Zitat Montenovo MI, Chambers K, Pellegrini CA, Oelschlager BK (2011) Outcomes of laparoscopic-assisted transhiatal esophagectomy for adenocarcinoma of the esophagus and esophago-gastric junction. Dis Esophagus 24:430–436CrossRefPubMed Montenovo MI, Chambers K, Pellegrini CA, Oelschlager BK (2011) Outcomes of laparoscopic-assisted transhiatal esophagectomy for adenocarcinoma of the esophagus and esophago-gastric junction. Dis Esophagus 24:430–436CrossRefPubMed
37.
Zurück zum Zitat Costi R, Himpens J, Bruyns J, Cadière GB (2004) Totally laparoscopic transhiatal esophago-gastrectomy without thoracic or cervical access. The least invasive surgery for adenocarcinoma of the cardia? Surg Endosc 18:629–632CrossRefPubMed Costi R, Himpens J, Bruyns J, Cadière GB (2004) Totally laparoscopic transhiatal esophago-gastrectomy without thoracic or cervical access. The least invasive surgery for adenocarcinoma of the cardia? Surg Endosc 18:629–632CrossRefPubMed
38.
Zurück zum Zitat Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS (2013) Comparison of totally laparoscopic total gastrectomy and open total gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A 23:323–331CrossRefPubMed Kim HS, Kim BS, Lee IS, Lee S, Yook JH, Kim BS (2013) Comparison of totally laparoscopic total gastrectomy and open total gastrectomy for gastric cancer. J Laparoendosc Adv Surg Tech A 23:323–331CrossRefPubMed
39.
Zurück zum Zitat Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520–530CrossRefPubMedPubMedCentral Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520–530CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Bo T, Peiwu Y, Feng Q, Yongliang Z, Yan S, Yingxue H, Huaxing L (2013) Laparoscopy-assisted vs. open total gastrectomy for advanced gastric cancer: long-term outcomes and technical aspects of a case-control study. J Gastrointest Surg 17:1202–1208CrossRefPubMed Bo T, Peiwu Y, Feng Q, Yongliang Z, Yan S, Yingxue H, Huaxing L (2013) Laparoscopy-assisted vs. open total gastrectomy for advanced gastric cancer: long-term outcomes and technical aspects of a case-control study. J Gastrointest Surg 17:1202–1208CrossRefPubMed
41.
Zurück zum Zitat Kim KT, Jeong O, Jung MR, Ryu SY, Park YK (2012) Outcomes of abdominal total gastrectomy for type II and III gastroesophageal junction tumors: single center’s experience in Korea. J Gastric Cancer 12:36–42CrossRefPubMedPubMedCentral Kim KT, Jeong O, Jung MR, Ryu SY, Park YK (2012) Outcomes of abdominal total gastrectomy for type II and III gastroesophageal junction tumors: single center’s experience in Korea. J Gastric Cancer 12:36–42CrossRefPubMedPubMedCentral
Metadaten
Titel
Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study
verfasst von
Chang-Ming Huang
Chen-Bin Lv
Jian-Xian Lin
Qi-Yue Chen
Chao-Hui Zheng
Ping Li
Jian-Wei Xie
Jia-Bin Wang
Jun Lu
Long-Long Cao
Mi Lin
Ru-Hong Tu
Publikationsdatum
15.12.2016
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 9/2017
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5375-y

Weitere Artikel der Ausgabe 9/2017

Surgical Endoscopy 9/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.